Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott E Kern

Showing results (1-10 of 108) with videos related to

Pageof 11
Sort By:
Cancer Biology & Therapy|August 13, 2002
Quantitative selection constantsScott E Kern
Cancer Biology & Therapy|August 6, 2010
Where's the passion?Scott E Kern
Cancer Biology & Therapy|August 13, 2002
Fellowship goals for PhDs and MDs: a primer on the molecular biology postdoctoral experienceScott E Kern
Cancer Biology & Therapy|December 24, 2002
Whose hypothesis? Ciphering, sectorials, D lesions, freckles and the operation of Stigler's LawScott E Kern
Cancer Research|November 23, 2012
Why your new cancer biomarker may never work: recurrent patterns and remarkable diversity in biomarker failuresScott E Kern
Cancer Biology & Therapy|June 25, 2013
"Selective cell death mediated by small conditional RNAs" is not selectiveKalpesh Patel, Scott E Kern
Cancer Biology & Therapy|May 17, 2003
The essential similarity of TGFbeta and activin receptor transcriptional responses in cancer cellsByungwoo Ryu, Scott E Kern
Cancer Research|October 3, 2007
The fuzzy math of solid tumor stem cells: a perspectiveScott E Kern, Darryl Shibata
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 4, 2007
Targeting Fanconi anemia/BRCA2 pathway defects in cancer: the significance of preclinical pharmacogenomic modelsEike Gallmeier, Scott E Kern
Cancer Biology & Therapy|August 6, 2005
Absence of specific cell killing of the BRCA2-deficient human cancer cell line CAPAN1 by poly(ADP-ribose) polymerase inhibitionEike Gallmeier, Scott E Kern
Pageof 11

Showing results (1-10 of 108) with videos related to

Sort By:
Pageof 11
Cancer Biology & Therapy|August 13, 2002
Quantitative selection constantsScott E Kern
Cancer Biology & Therapy|August 6, 2010
Where's the passion?Scott E Kern
Cancer Biology & Therapy|August 13, 2002
Fellowship goals for PhDs and MDs: a primer on the molecular biology postdoctoral experienceScott E Kern
Cancer Biology & Therapy|December 24, 2002
Whose hypothesis? Ciphering, sectorials, D lesions, freckles and the operation of Stigler's LawScott E Kern
Cancer Research|November 23, 2012
Why your new cancer biomarker may never work: recurrent patterns and remarkable diversity in biomarker failuresScott E Kern
Cancer Biology & Therapy|June 25, 2013
"Selective cell death mediated by small conditional RNAs" is not selectiveKalpesh Patel, Scott E Kern
Cancer Biology & Therapy|May 17, 2003
The essential similarity of TGFbeta and activin receptor transcriptional responses in cancer cellsByungwoo Ryu, Scott E Kern
Cancer Research|October 3, 2007
The fuzzy math of solid tumor stem cells: a perspectiveScott E Kern, Darryl Shibata
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 4, 2007
Targeting Fanconi anemia/BRCA2 pathway defects in cancer: the significance of preclinical pharmacogenomic modelsEike Gallmeier, Scott E Kern
Cancer Biology & Therapy|August 6, 2005
Absence of specific cell killing of the BRCA2-deficient human cancer cell line CAPAN1 by poly(ADP-ribose) polymerase inhibitionEike Gallmeier, Scott E Kern
Pageof 11